This is the authors' abstract. We don't add key points for this paper.
The 4-ethylphenyl sulfate (4-EPS) is considered a well-known gut microbiota derived metabolite that is involved in various human diseases and ailments. Thus, in the present work, an electrochemical sensor was developed using a polydopamine (PDA) based molecularly imprinted polymer (MIP) for the detection of 4-EPS, a gut metabolite using cyclic voltammetry (CV) for the first time. The synthesized PDA-MIP was characterized by fourier transform infrared spectroscopy (FTIR) and scanning electron microscopy (SEM) techniques. The PDA-MIP was drop casted on the surface of screen-printed carbon electrode (SPCE) to fabricate an electrochemical sensor. The developed PDA-MIP/SPCE sensor showed a broad linear detection range of 0.1–300 ng/mL (correlation, R 2 = 0.982) with a high sensitivity of 153.88 μA (log ng/mL) −1 cm −2 and a low limit of detection (LOD) of 0.018 ng/mL. The selectivity studies were also performed against the possible interfering compounds in human urine. The reproducibility of fabricated PDA-MIP/SPCE shows relative standard deviation (RSD) of 5.34%. For demonstrating the effectiveness of the sensor, the real sample analysis was performed in human urine and it shows the good recovery range of 98.1–121.8% with a RSD of 1.35–13.93%. Therefore, the MIP based electrochemical sensor is economically feasible, which may propose a new diagnostic method for identifying diseases associated with the concentration of 4-EPS in other body fluids.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Archana et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: